Holen Sie sich die Stockscreener-App
10.12
0.69%
-0.06
Schlusskurs vom Vortag:
$10.18
Offen:
$10.35
24-Stunden-Volumen:
103.76K
Relative Volume:
0.24
Marktkapitalisierung:
$1.36B
Einnahmen:
$58.49M
Nettoeinkommen (Verlust:
$-105.04M
KGV:
-7.7864
EPS:
-1.2997
Netto-Cashflow:
$-13.78M
1W Leistung:
-0.20%
1M Leistung:
+17.97%
6M Leistung:
+61.50%
1J Leistung:
+110.62%
1-Tages-Spanne:
$9.98
$10.35
1-Wochen-Bereich:
$9.39
$10.46
52-Wochen-Spanne:
$3.30
$12.41
Immatics N V Stock (IMTX) Company Profile
Compare IMTX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
10.14 | 1.36B | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.69 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
765.88 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
726.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
323.44 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
290.22 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-05-28 | Eingeleitet | Deutsche Bank | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-31 | Eingeleitet | Mizuho | Buy |
| 2023-03-24 | Eingeleitet | Bryan Garnier | Buy |
| 2020-11-20 | Eingeleitet | BofA Securities | Buy |
| 2020-09-22 | Eingeleitet | Goldman | Buy |
| 2020-07-27 | Eingeleitet | SVB Leerink | Outperform |
| 2020-07-24 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Immatics N V Aktie (IMTX) Neueste Nachrichten
Immatics NV earnings beat by €0.13, revenue topped estimates - Investing.com India
Immatics: Fourth Quarter Financial Overview - Bitget
Immatics: Q4 Earnings Snapshot - KVUE
IMTX Financial Assets Decline Due to R&D Spending and Exchange L - GuruFocus
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance - TipRanks
Immatics Earnings Report: Q4 Overview - Benzinga
Immatics (NASDAQ: IMTX) 2025 results show revenue drop and larger net loss - Stock Titan
Cancer therapy firm Immatics funds 2028 runway despite $231M 2025 loss - Stock Titan
immatics biotechnologies GmbH (IMTXW) Competitors - Meyka
(IMTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Immatics (NASDAQ:IMTX) Lowered to “Sell” Rating by Wall Street Zen - Defense World
IMTX SEC FilingsImmatics N.V 10-K, 10-Q, 8-K Forms - Stock Titan
Immatics N.V. (NASDAQ:IMTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Immatics N.V. (IMTX) Stock Analysis: Potential 91% Upside Amid Strong Buy Ratings - DirectorsTalk Interviews
Trade Report: Is PACK a defensive stockWeekly Trading Summary & Advanced Technical Signal Analysis - baoquankhu1.vn
Energy Moves: Is Immatics NV in a long term uptrendPortfolio Risk Summary & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Immatics (NASDAQ:IMTX) Trading Down 5% – Here’s What Happened - Defense World
IMTX PE Ratio & Valuation, Is IMTX Overvalued - Intellectia AI
Is Immatics N.V. a defensive stockQuarterly Trade Report & High Accuracy Swing Entry Alerts - mfd.ru
Aug Gainers: Whats next for Immatics NV Equity Warrant stockTrade Analysis Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Wall Street Zen Upgrades Immatics (NASDAQ:IMTX) to Hold - MarketBeat
Immatics N.V. (IMTX): Investor Outlook Reveals an 85% Upside Potential Amidst Groundbreaking Cancer Therapies - DirectorsTalk Interviews
RTW INVESTMENTS, LP Increases Stake in Immatics NV - GuruFocus
Can Immatics N.V. Equity Warrant expand into new marketsEarnings Recap Report & Smart Swing Trading Techniques - mfd.ru
Can Immatics N.V. Equity Warrant reach resistance levels soonJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - mfd.ru
Will Immatics N.V. (4A3) stock gain from green policiesBuy Signal & Reliable Momentum Entry Alerts - mfd.ru
Immatics (NASDAQ:IMTX) Shares Down 5%Time to Sell? - MarketBeat
Liquidity Mapping Around (IMTX) Price Events - Stock Traders Daily
Exit Recap: Is Immatics NV a cyclical or defensive stockPortfolio Gains Report & Real-Time Market Trend Scan - baoquankhu1.vn
RTW Investments reveals 8.5% Immatics N.V. (IMTX) stake in Schedule 13G/A - Stock Titan
Institution Moves: Is Flushing Financial Corporation attractive at current valuationQuarterly Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
What Immatics (IMTX)'s Melanoma Orphan Drug Designation Means For Shareholders - Sahm
Immatics N.V. (IMTX) Stock Analysis: Near 93% Upside Potential Drives Investor Interest - DirectorsTalk Interviews
Does Immatics N.V. stock have upside surprise potentialQuarterly Earnings Report & Daily Technical Forecast Reports - mfd.ru
Can Immatics N.V. Equity Warrant be the next market leader2025 Key Highlights & Consistent Income Trade Ideas - mfd.ru
Immatics (IMTX) Receives FDA Orphan Status for Melanoma Treatmen - GuruFocus
Immatics (NASDAQ:IMTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Whale Trades: Will Immatics NV Equity Warrant benefit from government policyJuly 2025 News Drivers & Low Risk Entry Point Guides - baoquankhu1.vn
Pharma News: What is the target price for Immatics NV stockMarket Performance Summary & Expert Verified Movement Alerts - baoquankhu1.vn
Why (IMTX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Inflation Data: Is Immatics NV a cyclical or defensive stockQuarterly Trade Summary & Weekly High Return Forecasts - baoquankhu1.vn
Weekly Recap: Will Immatics NV Equity Warrant outperform its industry peersPortfolio Risk Report & Consistent Profit Alerts - baoquankhu1.vn
Is Immatics N.V. Equity Warrant stock undervalued vs historical averages2025 Key Lessons & Risk Controlled Swing Alerts - mfd.ru
Loss Report: Will Immatics N.V. Equity Warrant benefit from current market trends2025 Pullback Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Immatics N.V. (NASDAQ:IMTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Volume Report: Should I set a stop loss on Immatics NVWeekly Investment Report & Expert Verified Movement Alerts - baoquankhu1.vn
Is Immatics N.V. Equity Warrant stock trending bullish2025 Price Momentum & Growth Oriented Trading Recommendations - mfd.ru
Immatics N.V. (IMTX) Stock Analysis: Exploring the 103.89% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
Can Immatics N.V. Equity Warrant generate free cash flowInsider Selling & Risk Controlled Stock Alerts - mfd.ru
Understanding Momentum Shifts in (IMTX) - Stock Traders Daily
What’s the outlook for Immatics N.V.’s sectorInsider Selling & Long-Term Growth Plans - mfd.ru
Finanzdaten der Immatics N V-Aktie (IMTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):